Intel

Key Takeaways Rapid growth in regenerative and alternative therapies is expanding Healthcare Liability exposures across medspas and healthcare providers. Coverage considerations are multifaceted, with many carriers applying exclusions, limitations, and strict underwriting requirements for non-FDA-approved and off-label treatments. A complex regulatory environment, driven by both federal and state oversight, impacts how Healthcare Liability risks are evaluated and underwritten Many claims stem from insufficient informed consent, patient screening, and marketing practices…

Misleading marketing materials, website content and social media posts can quickly become a significant Healthcare Liability exposure. In this short clip from our recent webinar on regenerative and alternative therapies, Lily Chetosky, Broker, Professional Liability, Burns & Wilcox, Chicago, Illinois, explains how patient expectations shaped by marketing can lead to costly claims. https://vimeo.com/1177367526/0dad2278f1?share=copy&fl=sv&fe=ci